In the past two decades, high quality genetic, transcriptomic, protein, enzymatic, and pharmacotherapeutic studies have consistently highlighted reduced mitochondrial function associated with bipolar depression
BPC 157 is used for its potential benefits in healing, recovery, and reducing inflammation
It remains a compound that requires a prescription and access through a licensed compounding pharmacy
In addition, these guidelines do not explicitly state whether this cut-off is expressed in NE base or salt formulation, an issue that is gaining in attention [14]
What can be said is that they sit on very different evidence tiers: tesamorelin is FDA-approved with multiple Phase 3 randomized trials for reducing visceral fat in HIV-associated lipodystrophy, while CJC-1295 is unapproved, with only two small early-phase human studies measuring GH and IGF-1 surrogates
Neurochem Res